Atomera is expected to report a Q2 2026 loss of $0.13 per share on revenue of $0.10 million, with its current stock price of $5.16 trading at a significant discount to the $10.20 analyst consensus price target.
Investors are primarily focused on the commercialization of Mears Silicon Technology (MST) and whether the company can finally secure a high-volume, production-scale licensing agreement.
While the company recently secured $25 million in equity funding and reported progress in GaN-on-Silicon development with Sandia National Labs, it continues to face persistent losses and minimal revenue. Management’s commentary on the timeline for royalty-bearing production will be the critical driver for stock sentiment following the report.